Large gap with delayed quotes
|
Last quote
01/06/2025 -
17:31:17
|
Bid
01/06/2025 -
17:17:55
|
Bid Volume |
Ask
01/06/2025 -
17:19:57
|
Ask Volume |
|---|---|---|---|---|
|
9.35
+0.21
(
+2.30% )
|
9.35
|
210 |
9.38
|
598 |
Analysis date: 03.01.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 06.12.2024.
Interest
Weak
Weak
Weak interest since 27.12.2024.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 25.10.2024 at a price of 9.86.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, at its current price the stock is fairly valued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 14.06.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is
4wk Rel Perf
8.83%
8.83%
The four week relative overperformance versus STOXX600 is 8.83%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 19.07.2024.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 0.93%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.73%.
Mkt Cap in $bn
0.41
0.41
With a market capitalization <$2bn, MEDMIX AG is considered a small-cap stock.
G/PE Ratio
0.60
0.60
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
31.85
31.85
The estimated PE is for the year 2026.
LT Growth
12.09%
12.09%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
7.11%
7.11%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
124
124
For 1% of index variation, the stock varies on average by 1.24%.
Correlation
0.45
0.45
45.13% of stock movements are explained by index variations.
Value at Risk
2.43
2.43
The value at risk is estimated at CHF 2.43. The risk is therefore 26.56%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.10.2022
21.10.2022